These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Context-Specific Function of the Engineered Peptide Domain of PHP.B. Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767 [TBL] [Abstract][Full Text] [Related]
30. Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity. Judd J; Wei F; Nguyen PQ; Tartaglia LJ; Agbandje-McKenna M; Silberg JJ; Suh J Mol Ther Nucleic Acids; 2012 Nov; 1(11):e54. PubMed ID: 23629029 [TBL] [Abstract][Full Text] [Related]
31. Reciprocal mutations of lung-tropic AAV capsids lead to improved transduction properties. Cooney AL; Brommel CM; Traore S; Newby GA; Liu DR; McCray PB; Sinn PL Front Genome Ed; 2023; 5():1271813. PubMed ID: 38077224 [TBL] [Abstract][Full Text] [Related]
32. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. Sonntag F; Köther K; Schmidt K; Weghofer M; Raupp C; Nieto K; Kuck A; Gerlach B; Böttcher B; Müller OJ; Lux K; Hörer M; Kleinschmidt JA J Virol; 2011 Dec; 85(23):12686-97. PubMed ID: 21917944 [TBL] [Abstract][Full Text] [Related]
33. Nuclear translocation of adeno-associated virus type 2 capsid proteins for virion assembly. Popa-Wagner R; Sonntag F; Schmidt K; King J; Kleinschmidt JA J Gen Virol; 2012 Sep; 93(Pt 9):1887-1898. PubMed ID: 22694902 [TBL] [Abstract][Full Text] [Related]
34. Characterization of tissue tropism determinants of adeno-associated virus type 1. Hauck B; Xiao W J Virol; 2003 Feb; 77(4):2768-74. PubMed ID: 12552020 [TBL] [Abstract][Full Text] [Related]
35. Direct Liquid Chromatography/Mass Spectrometry Analysis for Complete Characterization of Recombinant Adeno-Associated Virus Capsid Proteins. Jin X; Liu L; Nass S; O'Riordan C; Pastor E; Zhang XK Hum Gene Ther Methods; 2017 Oct; 28(5):255-267. PubMed ID: 28627251 [TBL] [Abstract][Full Text] [Related]
36. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors. Lam AK; Frabutt D; Li L; Xiao W Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844 [TBL] [Abstract][Full Text] [Related]
37. Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors. Giles AR; Govindasamy L; Somanathan S; Wilson JM J Virol; 2018 Oct; 92(20):. PubMed ID: 30089698 [TBL] [Abstract][Full Text] [Related]
38. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. Girod A; Wobus CE; Zádori Z; Ried M; Leike K; Tijssen P; Kleinschmidt JA; Hallek M J Gen Virol; 2002 May; 83(Pt 5):973-978. PubMed ID: 11961250 [TBL] [Abstract][Full Text] [Related]
39. Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction. Johnson JS; Li C; DiPrimio N; Weinberg MS; McCown TJ; Samulski RJ J Virol; 2010 Sep; 84(17):8888-902. PubMed ID: 20573820 [TBL] [Abstract][Full Text] [Related]
40. Structural characterization of an envelope-associated adeno-associated virus type 2 capsid. Hull JA; Mietzsch M; Chipman P; Strugatsky D; McKenna R Virology; 2022 Jan; 565():22-28. PubMed ID: 34638006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]